US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist

2.550
-0.040-1.54%

Close Apr 18 16:00 ET

2.590
+0.040+1.56%

Post 16:18 ET

77.97MMarket Cap-414P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

268.00%1.38M

57.98%376K

148.91%341K

457K

206K

375K

238K

137K

Operating revenue

268.00%1.38M

57.98%376K

148.91%341K

--457K

--206K

--375K

--238K

--137K

--0

Cost of revenue

6,200.00%1.26M

7,833.33%714K

4,554.55%512K

26K

20K

11K

Gross profit

-66.20%120K

-247.60%-338K

-235.71%-171K

431K

197K

355K

229K

126K

Operating expense

4.84%167.74M

-63.22%19.54M

12.39%43.96M

45.63%52.85M

63.26%51.4M

49.62%160M

103.29%53.12M

45.89%39.12M

31.42%36.29M

19.34%31.48M

Selling and administrative expenses

21.31%83.41M

-53.53%9.6M

42.75%24.34M

40.75%25.87M

82.61%23.6M

26.80%68.76M

51.86%20.66M

14.62%17.05M

30.33%18.38M

11.02%12.92M

-Selling and marketing expense

-4.01%12.49M

-92.15%319K

9.17%2.99M

1.89%4.81M

----

--13.01M

--4.07M

--2.74M

33.80%4.72M

----

-General and administrative expense

27.21%70.93M

-44.07%9.28M

49.17%21.36M

54.17%21.06M

82.61%23.6M

2.82%55.76M

21.98%16.6M

-3.78%14.32M

29.18%13.66M

11.02%12.92M

Research and development costs

-7.58%84.33M

-69.40%9.93M

-11.07%19.62M

50.64%26.97M

49.79%27.8M

73.10%91.24M

159.15%32.46M

84.88%22.06M

32.55%17.91M

25.90%18.56M

Operating profit

-4.99%-167.62M

62.42%-19.88M

-13.19%-44.13M

-44.44%-52.41M

-62.64%-51.2M

-49.29%-159.65M

-102.41%-52.89M

-45.42%-38.99M

-31.42%-36.29M

-19.34%-31.48M

Net non-operating interest income expense

-34.83%-7.67M

-73.57%-2.49M

24.09%-2.18M

-18.52%-1.64M

-17,000.00%-1.35M

-142,225.00%-5.69M

-24,000.00%-1.43M

-287,800.00%-2.88M

-22,933.33%-1.38M

166.67%8K

Non-operating interest income

123.46%5.65M

-36.34%946K

29.77%1.07M

694.61%1.62M

13,333.33%2.02M

5,645.45%2.53M

--1.49M

--823K

1,940.00%204K

50.00%15K

Non-operating interest expense

62.11%13.31M

17.64%3.44M

-12.11%3.25M

105.49%3.26M

48,000.00%3.37M

20,432.50%8.21M

--2.92M

--3.7M

9,812.50%1.59M

0.00%7K

Other net income (expense)

-782.67%-3.77M

122.50%108K

-6,822.58%-4.17M

537K

-246K

-427K

-480K

62K

Special income (charges)

---4.16M

--0

---4.16M

----

--0

----

-Less：Restructuring and merger&acquisition

--4.16M

--0

--4.16M

----

--0

----

Other non- operating income (expenses)

192.27%394K

122.50%108K

-108.06%-5K

--537K

---246K

---427K

---480K

--62K

----

Income before tax

-8.02%-179.05M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.78%-54.81M

-55.92%-41.81M

-36.39%-37.67M

-19.32%-31.47M

Income tax

Net income

-8.02%-179.05M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.78%-54.81M

-55.92%-41.81M

-36.39%-37.67M

-19.32%-31.47M

Net income continuous Operations

-8.02%-179.05M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.78%-54.81M

-55.92%-41.81M

-36.39%-37.67M

-19.32%-31.47M

Minority interest income

Net income attributable to the parent company

-8.02%-179.05M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.79%-54.81M

-55.92%-41.81M

-36.39%-37.67M

-19.32%-31.47M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-8.02%-179.05M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.79%-54.81M

-55.92%-41.81M

-36.39%-37.67M

-19.32%-31.47M

Basic earnings per share

-3.89%-6.15

61.54%-0.75

-15.44%-1.72

-35.56%-1.83

-64.29%-1.84

-46.17%-5.92

-109.68%-1.95

-55.21%-1.49

-21.62%-1.35

-3.70%-1.12

Diluted earnings per share

-3.89%-6.15

61.54%-0.75

-15.44%-1.72

-35.56%-1.83

-64.29%-1.84

-46.17%-5.92

-109.68%-1.95

-55.21%-1.49

-21.62%-1.35

-3.70%-1.12

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	268.00%1.38M	57.98%376K	148.91%341K	457K	206K	375K	238K	137K	0	0
Operating revenue	268.00%1.38M	57.98%376K	148.91%341K	--457K	--206K	--375K	--238K	--137K	--0	--0
Cost of revenue	6,200.00%1.26M	7,833.33%714K	4,554.55%512K	26K	9K	20K	9K	11K	0	0
Gross profit	-66.20%120K	-247.60%-338K	-235.71%-171K	431K	197K	355K	229K	126K	0	0
Operating expense	4.84%167.74M	-63.22%19.54M	12.39%43.96M	45.63%52.85M	63.26%51.4M	49.62%160M	103.29%53.12M	45.89%39.12M	31.42%36.29M	19.34%31.48M
Selling and administrative expenses	21.31%83.41M	-53.53%9.6M	42.75%24.34M	40.75%25.87M	82.61%23.6M	26.80%68.76M	51.86%20.66M	14.62%17.05M	30.33%18.38M	11.02%12.92M
-Selling and marketing expense	-4.01%12.49M	-92.15%319K	9.17%2.99M	1.89%4.81M	----	--13.01M	--4.07M	--2.74M	33.80%4.72M	----
-General and administrative expense	27.21%70.93M	-44.07%9.28M	49.17%21.36M	54.17%21.06M	82.61%23.6M	2.82%55.76M	21.98%16.6M	-3.78%14.32M	29.18%13.66M	11.02%12.92M
Research and development costs	-7.58%84.33M	-69.40%9.93M	-11.07%19.62M	50.64%26.97M	49.79%27.8M	73.10%91.24M	159.15%32.46M	84.88%22.06M	32.55%17.91M	25.90%18.56M
Operating profit	-4.99%-167.62M	62.42%-19.88M	-13.19%-44.13M	-44.44%-52.41M	-62.64%-51.2M	-49.29%-159.65M	-102.41%-52.89M	-45.42%-38.99M	-31.42%-36.29M	-19.34%-31.48M
Net non-operating interest income expense	-34.83%-7.67M	-73.57%-2.49M	24.09%-2.18M	-18.52%-1.64M	-17,000.00%-1.35M	-142,225.00%-5.69M	-24,000.00%-1.43M	-287,800.00%-2.88M	-22,933.33%-1.38M	166.67%8K
Non-operating interest income	123.46%5.65M	-36.34%946K	29.77%1.07M	694.61%1.62M	13,333.33%2.02M	5,645.45%2.53M	--1.49M	--823K	1,940.00%204K	50.00%15K
Non-operating interest expense	62.11%13.31M	17.64%3.44M	-12.11%3.25M	105.49%3.26M	48,000.00%3.37M	20,432.50%8.21M	--2.92M	--3.7M	9,812.50%1.59M	0.00%7K
Other net income (expense)	-782.67%-3.77M	122.50%108K	-6,822.58%-4.17M	537K	-246K	-427K	-480K	62K
Special income (charges)	---4.16M	--0	---4.16M	----	----	--0	--0	--0	----	----
-Less：Restructuring and merger&acquisition	--4.16M	--0	--4.16M	----	----	--0	--0	--0	----	----
Other non- operating income (expenses)	192.27%394K	122.50%108K	-108.06%-5K	--537K	---246K	---427K	---480K	--62K	----	----
Income before tax	-8.02%-179.05M	59.39%-22.26M	-20.77%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.78%-54.81M	-55.92%-41.81M	-36.39%-37.67M	-19.32%-31.47M
Income tax
Net income	-8.02%-179.05M	59.39%-22.26M	-20.77%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.78%-54.81M	-55.92%-41.81M	-36.39%-37.67M	-19.32%-31.47M
Net income continuous Operations	-8.02%-179.05M	59.39%-22.26M	-20.77%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.78%-54.81M	-55.92%-41.81M	-36.39%-37.67M	-19.32%-31.47M
Minority interest income
Net income attributable to the parent company	-8.02%-179.05M	59.39%-22.26M	-20.77%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.79%-54.81M	-55.92%-41.81M	-36.39%-37.67M	-19.32%-31.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-8.02%-179.05M	59.39%-22.26M	-20.77%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.79%-54.81M	-55.92%-41.81M	-36.39%-37.67M	-19.32%-31.47M
Basic earnings per share	-3.89%-6.15	61.54%-0.75	-15.44%-1.72	-35.56%-1.83	-64.29%-1.84	-46.17%-5.92	-109.68%-1.95	-55.21%-1.49	-21.62%-1.35	-3.70%-1.12
Diluted earnings per share	-3.89%-6.15	61.54%-0.75	-15.44%-1.72	-35.56%-1.83	-64.29%-1.84	-46.17%-5.92	-109.68%-1.95	-55.21%-1.49	-21.62%-1.35	-3.70%-1.12
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall